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compared to the other subpopulations. CD105 and Runx2 were shown by
immunohistochemistry and genetic analysis to have signiﬁcantly higher
expression CD271+ subpopulation than the other subpopulations.
Conclusions: Spheroids formed from CD271-enriched and CD73-enriched
MSCs from normal human synovial membranes mimic the native cartilage
extracellular matrix more closely than CD106+ MSCs and are possible
candidates for use in cartilage tissue engineering. Both cell types have
potential for promoting the differentiation of MSCs into chondrocytes,
presenting new possibilities for achieving intrinsic cartilage repair.
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Purpose: Therapeutic gene transfer might be a means to enhance the
reparative activities in articular cartilage lesions. We previously reported
that recombinant adeno-associated viral (rAAV) vectors are capable of de-
livering transgene sequences to articular cartilage defects in experimental
models over extended periods of time. In the present study, we tested the
hypothesis that eﬃcient and sustained overexpression of IGF-I via direct
application of rAAV enhances the healing of osteochondral defects created
in the knee joints of rabbits in vivo.
Methods: rAAV were packaged, puriﬁed by dialysis, and titrated by real-
time PCR. rAAV-lacZ carries the E. coli beta-galactosidase (β-gal) marker
gene (lacZ) controlled by the CMV-IE promoter/enhancer. A human insulin-
like growth factor-I (hIGF-I) cDNA was cloned in rAAV-lacZ instead of lacZ
to produce rAAV-hIGF-I. Two osteochondral defects (3.2-mm in diameter)
were created in each patellar groove of Chinchilla bastard rabbits (n = 8).
Each animal received alternatively 10 μ l rAAV-hIGF-I per defect on one
knee (IGF-I-treated defects) and 10 μl rAAV-lacZ per defect on the con-
tralateral knee (control defects). At 3 weeks post operation, cartilage repair
was assessed based on safranin O/hematoxylin eosin-stained sections using
a histological grading system. A total of 145 paraﬃn-embedded sections
(5 μm) were scored independently by two individuals that were blinded
with respect to the treatment. Points for each category and total score
were compared between the groups using a mixed general linear model
with repeated-measures analysis of variance. Indirect immunohistochemi-
cal staining was also performed to detect β-gal, hIGF-I, and type-II collagen.
The DNA, proteoglycan, and type-II collagen contents of the repair tissue
within the defects were measured using Hoechst 33258, by binding to
DMMB dye, and by ELISA, respectively. Data are expressed as mean ± SD.
The t-test and the Mann-Whitney Rank Sum Test were employed where
appropriate.
Figure 1. Safranin O staining (A, B) and type-II collagen immunoreactivity (C, D) in osteo-
chondral defects 3 weeks after vector application (A, C: rAAV-lacZ; B, D: rAAV-hIGF-I).
Magniﬁcation ×2.
Results: Following direct application of the vectors in vivo, there were no
signs of synovitis, adhesions, or adverse reactions, and no macroscopically
descriptive differences between the IGF-I-treated and control knees. β-gal
activity was restricted to the control defects, whereas IGF-I expression
was present only in the IGF-I-treated defects. After 3 weeks, enhanced
tissue healing was observed in the IGF-I-treated defects (Fig. 1). Improved
individual parameter scores were observed for defect ﬁlling, integration,
matrix staining, cellular morphology, defect and surface architecture, new
subchondral bone formation (all P<0.001) and tidemark (P<0.01) of the
IGF-I-treated defects, with also a signiﬁcantly improved total score vis a
vis control treatment (P<0.001). Immunoreactivity to type-II collagen was
more intense and regular in the IGF-I-treated defects (Fig. 1). Biochemical
analyses performed on the repair tissue from the defects revealed that
treatment with rAAV-hIGF-I promoted a signiﬁcant increase in the DNA
(3.2-fold; P<0.001), proteoglycan (1.2-fold; P = 0.01), and type-II collagen
contents (2.8-fold; P<0.001).
Conclusions: The data indicate that IGF-I can be overexpressed in osteo-
chondral defects in vivo via rAAV transduction, leading to the production
of a recombinant IGF-I factor that is capable of signiﬁcantly improving the
healing of the defects, stimulating both cell proliferation and extracellular
matrix synthesis. The results suggest that therapeutic rAAV may have value
in enhancing cartilage repair by application to sites of cartilage damage.
Further studies are required to evaluate the long-term properties of the
repair tissue.
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Purpose: Cartilage defects arise primarily due to traumatic or degenerative
changes and in the medium to long-term often result in osteoarthritis and
total joint replacement. One aim of modern orthopaedics is to avoid TJR.
For traumatic and small focal degenerative cartilage defects, in the recent
years promising treatment options like lavage, abrasion, osteochondral au-
tograft transfer, microfracture, cell-free implants, autologous chondrocyte
transplantation and matrix assisted ACT have been developed. However,
these therapies cannot completely arrest OA progression and currently are
not applied for the treatment of large OA defects. This is partly due to
a lack of knowledge regarding the cellular and molecular characteristics
of OA chondrocytes. The extracellular matrix is the functional element in
cartilage and its degradation is central in the pathogenetic process in OA.
In addition, new formation of ECM is crucial in OA chondrocyte based
therapies. Therefore, the aim of our study was to provide a more complete
picture of the cellular and molecular alterations in OA cartilage and to
analyze cartilage formation by OA-chondrocytes.
Methods: Human articular cartilage biopsies were collected from OA
patients as well as healthy normal donors. RNA was isolated from the
biopsies and subjected to genome-wide microarray analysis. Important
results were veriﬁed using qPCR and immunohistochemistry. Furthermore,
chondrocytes were harvested from such biopsies applying protocols used
for ACT. Their chondrogenic potential was studied in high-density pel-
let and hyaff-11 cultures by proteoglycan and collagen type II staining.
Moreover, chondrocytes cultured in monolayer and hyaff-11 scaffolds were
subjected to microarray gene expression proﬁling. Again, expression data
were veriﬁed by qPCR.
Results: We detected genes already associated with normal cartilage and
alterations in OA cartilage but also detected new candidates not previously
associated with this disease. Here, the expression of genes coding for colla-
gens (COL8A2, COL13-15A1) or related to bone formation (CLEC3B, CDH11,
GPNMB, CLEC3A, CHST11, MSX1-2) was signiﬁcantly higher in native OA
cartilage than in native ND cartilage. In 3D hyaff-11 cultures, chondrocytes
from ND and OA donors secreted comparable amounts of ECM components
like proteoglycans and collagen type II. Expression of cartilage marker
genes (ACAN, COL2A1, COMP, SOX9) and genes involved in matrix syn-
thesis (BGN, COL9A2, COL11A1) was highly induced in 3D ND and OA
